Dissecting the nutrigenomics, diabetes, and gastrointestinal disease interface: From risk assessment to health intervention

OMICS A Journal of Integrative Biology

Volumn 12, Issue 4, 2008, Pages 237-244

  Ferguson, Lynnette R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN DERIVATIVE; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLINIDE DERIVATIVE; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSIDASE ANTAGONIST; HOMEODOMAIN PROTEIN; INSULIN; INSULINASE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; IRON BINDING PROTEIN; MEMBRANE PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN CDKAL1; PROTEIN FTO; PROTEIN HHEX; PROTEIN SERINE THREONINE KINASE; PROTEIN SLC30A8; PROTEIN WOLFRAM SYNDROME 1; SOMATOMEDIN BINDING PROTEIN 2; SULFONYLUREA DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG;

CARBOHYDRATE INTAKE; DIABETES MELLITUS; DIET THERAPY; DISEASE CONTROL; EXERCISE; GASTROINTESTINAL DISEASE; GENE FUNCTION; HUMAN; KINESIOTHERAPY; MEDITERRANEAN DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIGENOMICS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION;

DIABETES MELLITUS, TYPE 2; DIET; EXERCISE; GASTROINTESTINAL DISEASES; GENOTYPE; HUMANS; NUTRIGENOMICS; RISK ASSESSMENT;

EID: 57149097728     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2008.0044     Document Type: Review

References (73)

1. Altshuler, D., Hirschhorn, J.N., Klannemark, M., Lindgren, C.M., Vohl, M.C., Nemesh, J., et al. (2000). The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26, 76-80.
2. Andreasen, C.H., Stender-Petersen, K.L., Mogensen, M.S., Torekov, S.S., Wegner, L., Andersen, G., et al. (2008). Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 57, 95-101.
3. Arkadianos, I., Valdes, A.M., Marinos, E., Florou, A., Gill, R.D., and Grimaldi, K.A. (2007). Improved weight management using genetic information to personalize a calorie controlled diet. Nutr J 6, 29.
4. Barclay, A.W., Petocz, P., McMillan-Price, J., Flood, V.M., Prvan, T., Mitchell, P., et al. (2008). Glycemic index, glycemic load, and chronic disease risk - a meta-analysis of observational studies. Am J Clin Nutr 87, 627-637.
5. Barroso, I., Gurnell, M., Crowley, V.E., Agostini, M., Schwabe, J.W., SOOS, M.A., et al. (1999). Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880-883.
6. Barzi, F., Woodward, M., Marfisi, R.M., Tavazzi, L., Valagussa, F., Marchioli, R., et al. (2003). Mediterranean diet and allcauses mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr 57, 604-611.
7. Cani, P.D., and Delzenne, N.M. (2007). Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 10, 729-734.
8. Castle, D., and Ries, N.M. (2007). Ethical, legal and social issues in nutrigenomics: the challenges of regulating service delivery and building health professional capacity. Mutat Res 622, 138-143.
9. Debusk, R.M., Fogarty, C.P., Ordovas, J.M., Kornman, K.S. (2005). Nutritional genomics in practice: where do we begin? J Am Diet Assoc 105, 589-598.
10. de Lorgeril, M., Salen, P., Martin, J.L., Monjaud, I., Delaye, J., and Mamelle, N. (1999). Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99, 779-785.
11. Esmaillzadeh, A., Kimiagar, M., Mehrabi, Y., Azadbakht, L., Hu, F.B., Willett, W.C. (2007). Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr 85, 910-918.
12. Fanella, S., Harris, S.B., Young, T.K., Hanley, A.J., Zinman, B., Connelly, P.W., et al. (2000). Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations. Clin Chem Lab Med 38, 413-420.
13. Ferguson, L.R. (2006). Nutrigenomics: integrating genomic approaches into nutrition research. Mol Diag Ther 10, 101-108.
14. Frayling, T.M. (2007). Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8, 657-662.
15. Frayling, T.M., Timpson, N.J., Weedon, M.N., Zeggini, E., Freathy, R.M., Lindgren, C.M., et al. (2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894.
16. Fung, T.T., Hu, F.B., Pereira, M.A., Liu, S., Stampfer, M.J., Colditz, G.A., et al. (2002). Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr 76, 535-540.
17. Fung, T.T., McCullough, M., Van Dam, R.M. and Hu, F.B. (2007). A prospective study of overall diet quality and risk of type 2 diabetes in women. Diabetes Care 30, 1753-1757.
18. Giugliano, D., and Esposito, K. (2008). Mediterranean diet and metabolic diseases. Curr Opin Lipidol 19, 63-68.
19. Gloyn, A.L., Pearson, E.R., Antcliff, J.F., Proks, P., Bruining, G.J., Slingerland, A. S., et al. (2004). Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350, 1838-1849.
20. Gonzalez Sanchez, J.L., Proenza, A.M., Martinez Larrad, M.T., Ramis, J,M., Fernandez Perez, C., Palou, A., et al. (2003). The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. Clin Endocrinol (Oxf) 59, 476-481.
21. Grant, S.F., Thorleifsson, G, Reynisdottir, I., Benediktsson, R. Manolescu, A., Sainz, J., et al. (2006). Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38, 320-323.
22. Gudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J.T., Thorleifsson, G., Manolescu, A., et al. (2007). Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 39, 977-983.
23. Heidemann, C., Hoffmann, K., Spranger, J., Klipstein-Grobusch, K., Mohlig, M., Pfeiffer, A.F., et al. (2005). A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study cohort. Diabetologia 48, 1126-1134.
24. Holst, J. J. (2007). The physiology of glucagon-like peptide 1. Physiol Rev 87, 1409-1439.
25. Holst, J.J., and Deacon, C. F. (2005). Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. Diabetologia 48, 612-615.
26. Howard, A.A., Arnsten, J.H., and Gourevitch, M.N. (2004). Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med 140, 211-219.
27. Hu, F.B. (2003). The Mediterranean diet and mortality: olive oil and beyond. N Engl J Med 348, 2595-2596.
28. Inoue, H., Tanizawa, Y., Wasson, J., Behn, P., Kalidas, K., Bernal-Mizrachi, E., et al. (1998). A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20, 143-148.
29. Kaput, J. (2008). Nutrigenomics research for personalized nutrition and medicine. Curr Opin Biotechnol 19:110-120.
30. Kaput, J., and Dawson, K. (2007). Complexity of type 2 diabetes mellitus data sets emerging from nutrigenomic research: a case for dimensionality reduction? Mutat Res 622, 19-32.
31. Kaput, J., Ordovas, J. M., Ferguson, L., Van Ommen, B., Rodriguez, R. L., Allen, L., et al. (2005). The case for strategic international alliances to harness nutritional genomics for public and personal health. Br J Nutr 94, 623-632.
32. Kilpelainen, T.O., Lakka, T.A., Laaksonen, D.E., Mager, U., Salopuro, T., Kubaszek, A., et al. (2008). Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: the Finnish Diabetes Prevention Study. Metab Clin Exp 57, 428-436.
33. Koh-Banerjee, P., Franz, M., Sampson, L., Liu, S., Jacobs, D.R., Spiegelman, D., et al. (2004). Changes in whole-grain, bran, and cereal fiber consumption in relation to 8-y weight gain among men. Am J Clin Nutr 80, 1237-1245.
34. Kornman, K., Rogus, J., Roh-Schmidt, H., Krempin, D., Davies, A.J., Grann, K., et al. (2007). Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept. Nutrition 23, 844-852.
35. Kubaszek, A., Pihlajamaki, J., Komarovski, V., Lindi, V., Lindstrom, J., Eriksson, J., et al. (2003). Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type-2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 52, 1872-1876.
36. Leipold, H., Knofler, M., Gruber, C., Haslinger, P., Bancher-Todesca, D., and Worda, C. (2004). Calpain-10 haplotype combination and association with gestational diabetes mellitus. Obstet Gynecol 103, 1235-1240.
37. Li, M., Wang, B., Zhang, M., Rantalainen, M., Wang, S., Zhou, H., Zhang, Y., et al. (2008). Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 105, 2117-2122.
38. Lindi, V.I., Uusitupa, M.I., Lindstrom, J., Louheranta, A., Eriksson, J.G., Valle, T.T., et al. (2002). Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 51, 2581-2586.
39. Liu, S., Manson, J.E., Stampfer, M.J., Hu, F.B., Giovannucci, E., Colditz, G.A., et al. (2000). A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in US women. Am J Public Health 90, 1409-1405.
40. Lovejoy, J.C. (2005). The impact of nuts on diabetes and diabetes risk. Curr Diabetes Rep 5, 379-384.
41. Mantzoros, C.S., Williams, C.J., Manson, J.E., Meigs, J.B., and Hu, F. B. (2006). Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr 84, 328-335.
42. Marks, D.L., Boucher, N., Lanouette, C.M., Perusse, L., Brookhart, G., Comuzzie, A.G., et al. (2004). Ala67Thr polymorphism in the Agouti-related peptide gene is associated with inherited leanness in humans. Am J Med Genet A 126, 267-271.
43. Mazmanian, K.S., Round, J.L., and Kasper, D.L. (2008). A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625.
44. Meyer, K.A., Kushi, L.H., Jacobs, D.R., Jr., Slavin, J., Sellers, T.A., and Folsom, A.R. (2000). Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr 71, 921-930.
45. Montonen, J., Knekt, P., Harkanen, T., Jarvinen, R., Heliovaara, M., Aromaa, A., et al. (2005). Dietary patterns and the incidence of type 2 diabetes. Am J Epidemiol 161, 219-227.
46. Montonen, J., Knekt, P., Jarvinen, R., Aromaa, A., Reunanen, A. (2003). Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr 77, 622-629.
47. Murtaugh, M.A., Jacobs, D.R., Jr., Jacob, B., Steffen, L.M., and Marquart, L. (2003). Epidemiological support for the protection of whole grains against diabetes. Proc Nutr Soc 62, 143-149.
48. Mullard, A. (2008) The inside story. Nature 453, 578-580.
49. Nielsen, E.M., Hansen, L., Carstensen, B., Echwald, S.M., Drivsholm, T., GLUMER, C., et al. (2003). The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 52, 573-577.
50. Nishigori, H., Yamada, S., Kohama, T., Tomura, H., Sho, K., Horikawa, Y., et al. (1998). Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes 47, 1354-1355.
51. Nothlings, U., Schulze, M.B., Weikert, C., Boeing, H., van der Schouw, Y.T., Bamia, C., et al. (2008). Intake of vegetables, legumes, and fruit, and risk for all-cause, cardiovascular, and cancer mortality in a European diabetic population. J Nutr 138, 775-781.
52. Opperman, A.M., Venter, C.S., Oosthuizen, W., Thompson, R.L., and Vorster, H.H. (2004). Meta-analysis of the health effects of using the glycaemic index in meal-planning. Br J Nutr 92, 367-381.
53. Parikh, H., and Groop, L. (2004). Candidate genes for type 2 diabetes. Rev Endocr Metab Disord 5, 151-176.
54. Panagiotakos, D.B., Tzima, N., Pitsavos, C., Chrysohoou, C., Zampelas, A., Toussoulis, D., et al. (2007). The association between adherence to the Mediterranean diet and fasting indices of glucose homoeostasis: the ATTICA Study. J Am College Nutr 26, 32-38.
55. Pearson, H. (2008). Genetic testing for everyone. Nature 453, 570-571.
56. Priebe, M.G., Van Binsbergen, J.J., De Vos, R., and Vonk, R.J. (2008). Whole grain foods for the prevention of type 2 diabetes mellitus. Cochrane Database Syst Rev CD006061.
57. Reitman, M.L., and Schadt, E.E. (2007). Pharmacogenetics of metformin response: a step in the path toward personalized medicine. J Clin Invest 117, 1226-1229.
58. Romao, I., and Roth, J. (2008). Genetic and environmental interactions in obesity and type 2 diabetes. J Am Diet Assoc 108, S24-S28.
59. Sanchez-Corona, J., Flores-Martinnez, S.E., Machorro-Lazo, M.V., Galaviz-Hernandez, C., Moran-Moguel, M.C., Perea, F.J., et al. (2004). Polymorphisms in candidate genes for type 2 diabetes mellitus in a Mexican population with metabolic syndrome findings. Diabetes Res Clin Pract 63, 47-55.
60. Sandhu, M.S., Weedon, M.N., Fawcett, K.A., Wasson, J., Debenham, S.L., Daly, A., et al. (2007). Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 39, 951-953.
61. Serra-Majem, L., Roman, B., and Estruch, R. (2006). Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev 64, S27-S47.
62. Savage, D.B., Agostini, M., Barroso, I., Gurnell, M., Luan, J., Meirhaeghe, A., et al. (2002). Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet 31, 379-384.
63. Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., Willer, C.J., Li, Y., Duren, W.L., et al. (2007). A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345.
64. Wang, J., Armour, T., Geiss, L.S., and Engelgau, M.M. (2005). Obesity and diabetes: dual epidemics on the rise. Curr Opin Endocrinol Diabetes 12, 174-180.
65. Weiss, E.P., Brown, M.D., Shuldiner, A.R., and Hagberg, J.M. (2002). Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects. Physiol Genomics 10, 145-157.
66. WHO. (2005). Preventing Chronic Diseases: A Vital Investment. Geneva: World Health Organization.
67. Willett, W. (2005). Toward optimal health: Walter Willett, M.D., DR.P.H. discusses dietary guidelines. Journal of Women's Health 14, 679-683.
68. Xu, G., Kaneto, H., Laybutt, D.R., Duvivier-Kali, V.F., Trivedi, N., Suzuma, K., et al. (2007). Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: Possible contribution to impaired incretin effects in diabetes. Diabetes 56, 1551-1558.
69. Yates, T., Khunti, K., Bull, F., Gorely, T., and Davies, M.J. (2007). The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia. 50, 1116-1126.
70. Yi, Y., Dongmei, L., Phares, D.A., Weiss, E.P., Brandauer, J., and Hagberg, J.M. (2008). Association between KCNJ11 E23K genotype and cardiovascular and glucose metabolism phenotypes in older men and women. Experimental Physiology 93, 95-103.
71. Yi, Y., Dongmei, L., Phares, D.A., Weiss, E.P., Brandauer, J., and Hagberg, J.M. (2008). Association between KCNJ11 E23K genotype and cardiovascular and glucose metabolism phenotypes in older men and women. Experimental Physiology 93, 95-103.
72. Zeggini, E., Scott, L.J., Richa Saxena, R.,Voight, B.F., for the Diagram Consortium. (2008). Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40, 638-645.
73. Zeggini, E., Weedon, M.N., Lindgren, C.M., Frayling, T.M., Elliott, K.S., Lango, H., et al. (2007). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336-1341.